liferayexpo "Bioph Europe"

Why exhibit? 

Biotechnology has become the innovation engine for the pharmaceutical industry as a whole. Big Pharma has always  represented a major source of funding for ‘little biotech' and in the past, that has often been mostly about biotechnology companies needing seed money and operating cash.

Now it is more about pharmaceutical companies needing new innovations to feed their own pipelines. On the biotech side, advances in genomics, proteomics and other biotech research continue to bring about not only new drug molecules but also whole new therapeutic classes such as gene and cell therapies. Big Pharma is looking at biotech to infuse its own pipelines with more innovation.


BioPh Europe 2010 benefits: 

• 83.3% of BioPh exhibitors made more than 20 new business clients.
  (Exhibitor Survey 2009)

• BioPh is targeting senior buyers and C-level executives from all over the world.
• BioPh Highlights the latest knowledge and the newest trends. 

• 66,7% of BioPh exhibitors rated the show (BioPh, ICSE, P-MEC and CPhI) to be the
  most important event in the industry calendar. (Exhibitor Survey 2009)

• Provide a perfect synergy between ICSE and P-MEC Europe 2010.
• Held alongside CPhI, ICSE and P-MEC making it part of the largest event in the world
  of pharmaceuticals.

• 66,7% of BioPh Europe exhibitors rated the quality of visitors to be good.
  (Exhibitor Survey 2009)

• 41,1% of BioPh visitors has purchasing authority. (Visitor Survey 2009)
• 36,7% of BioPh visitors has an influence on buying. (Visitor Survey 2009)

 Important Exhibitor information

Contact the Sales Department for more information:

Sales Contact	Phone	Email
Mr. Krisztian Zsedely Sales Manager	+31 (0) 20 40 99 529
Ms. Ilona van den Berg Senior Sales Executive	+31 (0) 20 40 99 507
Mr. Vikram Rao Sales Executive	+31 (0) 20 40 99 524

When and Where BioPh: Bio Solutions for Pharma. 

When:

Where:
Paris Nord Villepinte
Parc d’expositions et Centre de Conventions
95970 Roissy Charles de Gaulle Cedex.
Click here for a technical overview of the Paris Nord Villepinte venue.